This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ljungman P, Plotkin SA . Workshop on CMV disease: definitions, clinical severity scores, and new syndromes Scand J Infect Dis Suppl 1995 99: 87–89
Humar A, St Louis P, Mazzulli T et al. Elevated serum cytokines are associated with cytomegalovirus infection and disease in hematopoietic stem cell transplant patients J Infect Dis 1999 179: 484–488
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graber, C., de Almeider, K., Childs, R. et al. CMV reactivation in nonmyeloablative HSCT. Bone Marrow Transplant 27, 775 (2001). https://doi.org/10.1038/sj.bmt.1702871
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702871
This article is cited by
-
High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
Bone Marrow Transplantation (2002)
-
Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin
Bone Marrow Transplantation (2002)
-
Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma
Bone Marrow Transplantation (2002)